References
- Valencia, X., C. Yarboro, G. Illei, and P. E. Lipsky. 2007. Deficient CD4+CD25high T regulatory cell function in patients with active systemic lupus erythematosus. J. Immunol. 178: 2579–2588
- Yan, B., S. Ye, G. Chen, et al. 2008. Dysfunctional CD4+,CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-alpha-producing antigen-presenting cells. Arthritis Rheum. 58: 801–812
- Shevach, E. M. 2009. Mechanisms of foxp3+ T regulatory cell-mediated suppression. Immunity. 30: 636–645
- Juang, Y. T., Y. Wang, E. E. Solomou, et al. 2005. Systemic lupus erythematosus serum IgG increases CREM binding to the IL-2 promoter and suppresses IL-2 production through CaMKIV. J. Clin. Invest. 115: 996–1005
- Koga, T., K. Ichinose, M. Mizui, et al. 2012. Calcium/calmodulin-dependent protein kinase IV suppresses IL-2 production and regulatory T cell activity in lupus. J. Immunol. 189: 3490–3496
- Ichinose, K., Y. T. Juang, J. C. Crispin, et al. 2011. Suppression of autoimmunity and organ pathology in lupus-prone mice upon inhibition of calcium/calmodulin-dependent protein kinase type IV. Arthritis Rheum. 63: 523–529
- Gunaratne, R., D. W. Braucht, M. M. Rinschen, et al. 2010. Quantitative phosphoproteomic analysis reveals cAMP/vasopressin-dependent signaling pathways in native renal thick ascending limb cells. Proc. Natl. Acad. Sci. USA. 107: 15653–15658
- Ichinose, K., T. Rauen, Y. T. Juang, et al. 2011. Cutting edge: calcium/calmodulin-dependent protein kinase type IV is essential for mesangial cell proliferation and lupus nephritis. J. Immunol. 187: 5500–5504
- Crispin, J. C., M. Oukka, G. Bayliss, et al. 2008. Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys. J. Immunol. 181: 8761–8766
- Okamoto, A., K. Fujio, N. H. Tsuno, et al. 2012. Kidney-infiltrating CD4+ T-cell clones promote nephritis in lupus-prone mice. Kidney Int. 82: 969–979
- Huehn, J., and A. Hamann. 2005. Homing to suppress: address codes for Treg migration. Trends Immunol. 26: 632–636
- Franz, B., B. Fritzsching, A. Riehl, et al. 2007. Low number of regulatory T cells in skin lesions of patients with cutaneous lupus erythematosus. Arthritis Rheum. 56: 1910–1920
- Almeida, A. R., N. Legrand, M. Papiernik, and A. A. Freitas. 2002. Homeostasis of peripheral CD4+ T cells: IL-2R alpha and IL-2 shape a population of regulatory cells that controls CD4+ T cell numbers. J. Immunol. 169: 4850–4860
- Cai, X. Y., M. Luo, X. J. Lin, et al. 2012. Expression and significance of Th17 and Treg cells in peripheral blood of patients with systemic lupus erythematosus. Zhonghua Yi Xue Za Zhi. 92: 460–463
- Parietti, V., F. Monneaux, M. Decossas, and S. Muller. 2008. Function of CD4+, CD25+ Treg cells in MRL/lpr mice is compromised by intrinsic defects in antigen-presenting cells and effector T cells. Arthritis Rheum. 58: 1751–1761
- Zhang, J. L., D. J. Sun, C. M. Hou, et al. 2010. CD3 mAb treatment ameliorated the severity of the cGVHD-induced lupus nephritis in mice by up-regulation of Foxp3+ regulatory T cells in the target tissue: kidney. Transplant. Immunol. 24: 17–25
- Miyara, M., Z. Amoura, C. Parizot, et al. 2005. Global natural regulatory T cell depletion in active systemic lupus erythematosus. J. Immunol. 175: 8392–8400